Dr. Barry Dworkin

Short-term solution available for those who cannot get an Epipen due to shortages

Health Headlines Commentary for August 23, 2018

Source:

Mom hesitates in using son’s EpiPen on herself amid shortage

 

Related posts:

  1. Allergy association with antibiotic and antacid use in infancy raises questions that should lead to other studies to answer them.
  2. Study concludes that there was no evidence to support vitamin D supplementation in the general population would improve COVID-19 outcomes.
  3. Availability of monoclonal antibody treatment for mild to moderate COVID is limited in Canada based on medication supply and availability of dedicated infusion centres and staff in some parts of the country.
  4. Many Canadians continue to choose Benadryl as their first choice for allergy medication despite messaging from Canadian Society of Allergy and Clinical Immunology recommending safer 2nd and 3rd generation antihistamines.